ARS Pharmaceuticals to Participate in Piper Sandler 37th Annual Healthcare Conference

Core Insights - ARS Pharmaceuticals, Inc. is participating in the Piper Sandler 37th Annual Healthcare Conference from December 2-4, 2025, in New York [1] - The company's management will engage in a fireside chat and one-on-one meetings with investors during the conference [2] Company Overview - ARS Pharmaceuticals is focused on empowering at-risk patients and their caregivers to manage allergic reactions that may lead to anaphylaxis [3] - The company is commercializing neffy® (EURneffy® in the EU), an epinephrine nasal spray for emergency treatment of Type I allergic reactions, including anaphylaxis, for patients aged 4 years and older in the U.S. and for various allergic reactions in the EU [3]